Lethal Mycobacterium bovis Bacillus Calmette Guerin infection in nitric oxide synthase 2-deficient mice: Cell-mediated immunity requires nitric oxide synthase 2

Laboratory Investigation

Volumn 80, Issue 9, 2000, Pages 1385-1397

  Garcia, Irene ^a   Guler, Reto ^a   Vesin, Dominique ^a   Olleros, Maria L ^a   Vassalli, Pierre ^a   Chvatchko, Yolande ^b   Jacobs, Muazzam ^c   Ryffel, Bernhard ^c  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL IMMUNITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME DEFICIENCY; GRANULOMA; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE ACTIVATION; TH1 CELL;

EID: 0033828603     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780146     Document Type: Article

References (52)

1. Exacerbation of acute and chronic murine tuberculosis by administration of a tumor necrosis factor receptor-expressing adenovirus
2. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency
3. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection
4. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resuiting in inactivation of TNF-alpha
5. Nitrite production by macrophages derived from BCG-resistant and -susceptible congenic mouse strains in response to IFN-gamma and infection with BCG
6. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum
7. Role of interferon-gamma in interleukin 12-induced pathology in mice
8. Immunological conditions of children with BCG disseminated infection
9. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis
10. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages
11. Disseminated tuberculosis in interferon gamma gene-disrupted mice
12. Interleukin 12 (IL-12) is crucial to the development of protectire immunity in mice intravenously infected with mycobactedum tuberculosis
13. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes
14. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients
15. Requirement for type 2 NO synthase for IL-12 signaling in innate immunity
16. Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection
17. Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line Raw 264.7
18. Perspectives series: Host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity
19. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor
20. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection
21. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice
22. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection
23. Effects of aminoguanidine on latent murine tuberculosis
24. Nitric oxide regulates interleukin-8 gene expression in activated endothelium by inhibiting NF-kappaB binding to DNA: Effects on endothelial function
25. Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections
26. High sensitivity of transgenic mice expressing soluble TNFR1 fusion protein to mycobacterial infections: Synergistic action of TNF and IFN-gamma in the differentiation of protective granulomas
27. Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene
28. Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages
29. Nitric oxide inhibits LPS-induced tumor necrosis factor synthesis in vitro and in vivo
30. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection
31. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis
32. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection
33. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages
34. Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide
35. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection
36. Expression of NO-synthase in cells of foreign-body and BCG-induced granulomata in mice: Influence of L-NAME on the evolution of the lesion
37. Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees
38. A role for lymphotoxin β receptor in host defense against Mycobacterium bovis BCG infection
39. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase
40. Identification of nitric oxide synthase as a protective locus against tuberculosis
41. Apoptosis-inducing agents cause rapid shedding of tumor necrosis factor receptor 1 (TNFR1). A nonpharmacological explanation for inhibition of TNF-mediated activation
42. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells
43. Nitric oxide blocks nuclear factor-kappaB activation in alveolar macrophages
44. Interleukin-12 gene-expression of macrophages is regulated by nitric oxide
45. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase
46. Mycobacterium avium: Pathogenicity in HIV1 infection
47. Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice
48. Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages
49. The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi
50. Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guerin in IL-12-deficient mice
51. Modulation of proinflammatory cytokines by nitric oxide in murine acute lung injury
52. Dissection of strain difference in acquired protective immunity against Mycobacterium bovis Calmette-Guerin bacillus (BCG). Macrophages regulate the susceptibility through cytokine network and the induction of nitric oxide synthase